Latest News

The indication for post-operative pain management has been removed The indication for the management of post-operative pain has been removed from the licenses of all…

A new clinical trial map is now available on the Clinical Trials Information System (CTIS) public website. The map is intended to offer patients and healthcare professionals…

Adults with cerebrotendinous xanthomatosis (CTX) can now be treated with Ctexli (chenodiol), which is approved by the US Food and Drug Administration. Also, it’s The…

For the purpose of improving glycemic control in adults and pediatric patients with diabetes mellitus, the U.S. Food and Drug Administration authorized Merilog (insulin-aspart-szjj) as…

In order to provide vital safety alerts, the U.S. Food and Drug Administration is warning patients about a safety issue with diabetic devices that rely…

Nemolizumab, also known as Nemluvio, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat moderate to severe prurigo nodularis in…

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of gozetotide (marketed under the name Illuccix) in a positioning emission tomography (PET)…

The MHRA has authorized the chikungunya vaccine (live) (brand name IXCHIQ) to prevent adults from chikungunya disease, which is caused by the chikungunya virus (CHIKV).…

The Medicines and Healthcare Products Regulatory Agency (MHRA) has opened a consultation on regulatory guidance for personalized mRNA cancer immunotherapies (also known as cancer vaccines).…

The EMA’s human medicines committee (CHMP) has issued a good scientific opinion on Ivermectin/Albendazole for the treatment of illnesses caused by a variety of worm…

The widespread use of azole fungicides (azoles), notably in some agricultural and horticultural operations, raises the possibility of Aspergillus fungus acquiring resistance to critical antifungal…

The FDA has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx alleviates…

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved garadacimab (brand name Andembry) for the prevention of angioedema attacks in individuals aged 12 and…

If approved, the United States would be the world’s first government to adopt such a bold, life-saving step to prevent and decrease smoking-related disease and…

Extra safety information is being added to all montelukast products, Montelukast is a prescription medicine used to prevent and treat chronic asthma in adults and…